Collaborative Programs

The SENSICAV project aims to develop a complete system for the selective treatment of neurological diseases using microbubble-assisted ultrasound cavitation, integrating a robot-assisted FUS source, wide-band CMUT matrix arrays, ultrasound imaging, and real-time feedback for optimal positioning and therapeutic dose control.

Le projet vise à structurer une plateforme ultrasonore OEM destinée à démocratiser l’échographie, depuis le dépistage précoce jusqu’au guidage interventionnel thérapeutique.

Le projet vise à remplacer le PZT à base de plomb dans les sondes échographiques miniaturisées en développant des céramiques BCTZ sans plomb de nouvelle génération, optimisées grâce à des procédés avancés de synthèse et de multi-dopage pour des transducteurs miniatures haute performance.

ThrombUS+ brings together an interdisciplinary team of industrial, technology, regulatory, social science and clinical trial experts to develop a novel wearable diagnostic device for point-of-care, operator free, continuous monitoring in patients with high DVT risk.

VERMON aims through the Run&Sense project to support the industrialization of innovative products dedicated to medical imaging, driven by a new industrial paradigm through automated processes from the microelectronic. These processes will make it possible to produce new ultrasound probes with high added value in large volumes. By this way, VERMON will be able to consolidate its international leadership in very high growth medical markets.

Med-IPUT aims to revolutionize medical imaging by developing advanced ultrasound and photoacoustic imaging technologies. The project will create a new generation of ultrasound imaging sensors that are more accurate, safer for patients and cost-effective.

The project aims to develop next-generation lead-free textured piezoelectric materials suitable for ultrasound imaging and therapy applications

RECAP aims to design a contactless energy transfer chain combining ultrasonic power transmission and energy harvesting in electrostatic form. The main challenge aims to optimize each element by developing, for the first time, mixed energy harvesting architectures, combining electrostatic and piezoelectric devices, and also high-efficiency electronic energy conversion architectures.

The goals of the project are to produce lead-free, dense, reliable and reproducible ceramics for a new generation of piezoelectric transducers and to industrialize a new plasma process.

The DIANA project aims to democratize targeting technologies by image fusion in the treatment of prostate cancer, by developing:
A/ a new generation of 3D ultrasound imaging
B/ artificial intelligence algorithms to automate, accelerate, optimize and improve the key stages of targeted interventions.

BOWMEMS aims to establish, on the CERTeM platform, a research and development toolset for the manufacturing of MEMS components by wafer bonding.

The MAPS project focuses on the development and evaluation of doped BCTZ-type compounds using a new synthesis technique in order to identify the most efficient dopings. The corresponding ceramics, with optimized electromechanical performances, are then integrated into a medical demonstrator in order to evaluate their ultrasonic performances.

New generations of active implantable medical devices requires miniaturization, communication and energy efficiency solutions. Tech2AIM therefore aimed to develop disruptive technological components with high added value around energy transfer by ultrasound and the functionalization of titanium (radiofrequency communication and electrocardiogram electrodes).

The project concerns the establishment of a manufacturing line for matrix ultrasound transducers for volumetric medical imaging for diagnostic purposes and to aid surgical interventions.

The objective of the project was to demonstrate the proof of concept of an ultrasound imaging sheath allowing the intracardiac introduction of medical devices.

The project aims to developed new highly accurate ultrasound technologies to produce 3D images of the vessel and blood flow. The researchers aimed to develop new imaging sensors, contrast fluids and analysis techniques to more accurately determine whether treatment is necessary.

The IRIS project aimed to use ultrasound to improve the delivery of an anticancer molecule, IL-12. This molecule has the ability to stimulate the immune system in humans, in order to fight against skin cancer.

The PIEZOCERA project consisted of developing the manufacturing toolset on a pre-industrial scale for lead-free piezoelectric ceramics, with performances compatible with military and civil applications.

The TOUCAN project aimed at realizing affordable and versatile 3D ultrasound diagnostics (through a specific matrix transducer) to be used in the clinic, in the daily life of patients and in biomedical research.

The NAUTIILE project focused on the design and development of new ultrasonic probes with a high level of integration, high frequency and lead-free.

DEPAC focused on the optimization and validation of the proof of concept of the ultrasound neurostimulation approach, in different animal models of depression.

The CHORUS project aimed to develop a new technique for treating cardiac arrhythmia through the transesophageal route using ultrasound therapy. A prototype of a bi-modal transducer (imaging and therapy) was produced and allowed in-vitro tests to verify the possibility of creating lesions in cardiac tissues.

The ambition of the POSITION II project was related to innovations in smart catheters and implants by the introduction of open technology platforms for: miniaturization, in-tip AD conversion, wireless communication, MEMS transducer technologies and encapsulation.

The overall objective of the PERFUSE project was to assess the oncologic results of focal treatment (FT) of prostate cancer and to propose a coherent set of innovations to allow a personalized and more rational FT, through a complete chain of novel tools, from diagnosis to technical rupture of HIFU treatment.

The main objective of the Ultrafast4D project was to allow 4D imaging capabilities using available commercial ultrafast scanners (128-256 channels) associated with smarter probe designs and novel imaging sequence schemes. The project was mainly focused on low cost ultrafast 4D cardiac imaging, a key differentiator for the involved partners - from prototype fabrication to in vivo cardiac volume ultrafast acquisitions on healthy volunteers.

The HeCATE project focused on the production of lead-free piezoelectric materials capable of achieving high electromagnetic performances. Ceramics, single crystals and textured ceramics, have been manufactured for medical and underwater applications. This project is part of the development of alternative materials to PZT, listed in European Union legislation as a dangerous substance.

Within the framework of Lab-TMEMS joint laboratory, GREMAN laboratory and VERMON have worked on piezoelectric devices for vibrational energy harvesting and for high intensity ultrasound generation.